[HTML][HTML] Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A/B

E Basar, H Mead, B Shum, I Rauter, C Ay… - Pharmaceutics, 2024 - mdpi.com
Biological barriers remain a major obstacle for the development of innovative therapeutics.
Depending on a disease's pathophysiology, the involved tissues, cell populations, and …

[HTML][HTML] Identification, Design, and Application of Noncoding Cis-Regulatory Elements

L Xu, Y Liu - Biomolecules, 2024 - mdpi.com
Cis-regulatory elements (CREs) play a pivotal role in orchestrating interactions with trans-
regulatory factors such as transcription factors, RNA-binding proteins, and noncoding RNAs …

AAV-mediated co-expression of an immunogenic transgene plus PD-L1 enables sustained expression through immunological evasion

TB McMurphy, A Park, PJ Heizer, C Bottenfield… - Scientific Reports, 2024 - nature.com
Adeno-associated virus (AAV) vectors can mediate long-term expression of immunogenic
transgenes in vivo through transduction of tolerogenic cells in the liver. Tissue-targeted AAV …

rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective and durable adaptive immune response with a single dose

KB Wiggins, SM Winston, IL Reeves, J Gaevert… - Journal of …, 2024 - journals.asm.org
Influenza remains a worldwide public health threat. Although seasonal influenza vaccines
are currently the best means of preventing severe disease, the standard-of-care vaccines …

Coarse-Grained Simulations of Adeno-Associated Virus and Its Receptor Reveal Influences on Membrane Lipid Organization and Curvature

N Pipatpadungsin, K Chao… - The Journal of Physical …, 2024 - ACS Publications
Adeno-associated virus (AAV) is a well-known gene delivery tool with a wide range of
applications, including as a vector for gene therapies. However, the molecular mechanism of …

A humanized mouse model for adeno-associated viral gene therapy

M Barzi, T Chen, TJ Gonzalez, FP Pankowicz… - Nature …, 2024 - nature.com
Clinical translation of AAV-mediated gene therapy requires preclinical development across
different experimental models, often confounded by variable transduction efficiency. Here …

CRISPR targeting of mmu-miR-21a through a single adeno-associated virus vector prolongs survival of glioblastoma-bearing mice

L Nieland, AB Vrijmoet, IW Jetten, D Rufino-Ramos… - Molecular Therapy, 2025 - cell.com
Glioblastoma (GB), the most aggressive tumor of the central nervous system (CNS), has
poor patient outcomes with limited effective treatments available. MicroRNA-21 (miR-21 (a)) …

αFAP-specific nanobodies mediate a highly precise retargeting of modified AAV2 capsids thereby enabling specific transduction of tumor tissues

O Olarewaju, F Held, P Curtis, CH Kenny… - … Therapy Methods & …, 2024 - cell.com
Due to the refractiveness of tumor tissues to adeno-associated virus (AAV) transduction,
AAV vectors are poorly explored for cancer therapy delivery. Here, we aimed to engineer …

AAV-DJ is superior to AAV9 for targeting brain and spinal cord, and de-targeting liver across multiple delivery routes in mice

M Chauhan, AL Daugherty, F Khadir… - Journal of Translational …, 2024 - Springer
Highly efficient adeno associated viruses (AAVs) targeting the central nervous system (CNS)
are needed to deliver safe and effective therapies for inherited neurological disorders. The …

RNA programmable cell targeting and manipulation with CellREADR

X Yang, K Woldemichael, J Hover, S Zhao, X Guo… - bioRxiv, 2024 - biorxiv.org
Methods that provide specific, easy, and scalable experimental access to animal cell types
and cell states will have broad applications in biology and medicine. CellREADR-Cell …